archive-com.com » COM » P » PWC.COM

Total: 2203

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • PwC pharmaceuticals: Pharma and life sciences tax news
    Analyst relations Global International PwC Sites Commonly visited PwC sites Global Australia Brazil Canada China Hong Kong France Germany India Italy Japan Mexico Middle East Netherlands Russia Singapore South Africa South Korea Spain Sweden Switzerland United Kingdom United States Complete list of PwC territory sites Pharma and life sciences tax news Welcome to PwC s Pharma and life sciences tax news Published by our global pharmaceuticals life sciences industry group these informational bulletins will periodically review developing tax issues new IRS pronouncements and tax legal rulings that affect the pharmaceutical and healthcare products industry Pharma and Life Sciences Tax News Vol 12 No 12 December 4 2013 Pharma and Life Sciences Tax News Vol 12 No 11 IRS Announces Deadlines for 2014 Branded Drug Fee August 9 2013 Pharma and Life Sciences Tax News Vol 12 No 10 Administration delays reporting enforcement of employer mandate for 2014 July 23 2013 Pharma and Life Sciences Tax News Vol 12 No 9 Portion of multiple damages payment treated as deductible by U S District Court in False Claims Act settlement Jun 26 2013 Pharma and Life Sciences Tax News Vol 12 No 8 Impact of recent IRS guidance on Section 199 to Pharmaceutical and Life Sciences companies May 30 2013 Pharma and Life Sciences Tax News Vol 12 No 7 Minimum royalties must be capitalized to ending inventory IRS concludes May 3 2013 Pharma and Life Sciences Tax News Vol 12 No 6 IRS disallowance of research credit for employee separation payments validates importance of documentation 30 April 2013 Pharma and Life Sciences Tax News Vol 12 No 5 UK budget introduces Patent Box regime and increases R D benefits reduces corporate tax rate to 20 5 April 2013 Pharma and Life Sciences Tax News Vol 12 No 4 The Puerto Rican

    Original URL path: http://www.pwc.com/gx/en/industries/pharmaceuticals-life-sciences/publications/pharma-life-sciences-tax-news-index.html (2016-02-10)
    Open archived version from archive


  • Medical Devices tax news: PwC
    Middle East Netherlands Russia Singapore South Africa South Korea Spain Sweden Switzerland United Kingdom United States Complete list of PwC territory sites Medical Devices tax news Welcome to PwC s Medical Device tax news Published by our global pharmaceuticals life sciences industry group these informational bulletins will periodically review developing tax issues new IRS pronouncements and tax legal rulings that affect the medical devices industry Medical Device Tax News January 2014 IRS Office of Chief Counsel issues private letter ruling on medical device excise tax convenience kit rules 9 January 2014 Medical Devices Tax News December 2012 IRS and Treasury publish regulations notice and FAQs implementing Medical Device Excise Tax 7 December 2012 Medical Device Tax News September 2012 IRS updates form to support tax free sales for medical device manufacturers and importers 27 September 2012 Medical Device Tax News June 2012 Ways and Means Committee approves bill that would repeal medical device excise tax 1 June 2012 Medical Device Tax News February 2012 IRS and Treasury publish notice of proposed rulemaking implementing new Medical Device Excise Tax 8 February 2012 Medical Device Tax News February 2012 IRS Treasury release guidance on new medical device excise tax 3 February 2012 Medical Devices Tax News August 2011 Med tech companies and the impact of excise tax on innovation 15 August 2011 Medical Devices Tax News August 2011 R D tax trends Creating a climate for innovation 2 August 2011 Medical Devices Tax News July 2011 JCT expands analysis of Obama administration proposal for permanent research credit 26 July 2011 Medical Devices Tax News December 2010 IRS and Treasury request comments on implementation of medical device excise tax 6 December 2010 Medical Devices Tax News October 2010 Federal Law On Innovation Centre Skolkovo 8 November 2010 Pharmaceuticals and life sciences Services Index

    Original URL path: http://www.pwc.com/gx/en/industries/pharmaceuticals-life-sciences/medtech.html (2016-02-10)
    Open archived version from archive

  • KnowledgeLine
    governance Our contribution to the debate Genesis Park Diversity and inclusion Analyst relations Alumni Member firms worldwide Live events and discussions Strategy Research insights View featured Browse by issue Browse by industry Browse by service Monthly highlights Spotlight The CEO agenda CEO insights blog Careers About PwC Technology careers Employer of choice Our history PwC Professional Employability Aspire to lead PwC s series on leadership and gender equality Country job search Explore careers with Strategy Press room Facts and figures Press contacts Analyst relations Global International PwC Sites Commonly visited PwC sites Global Australia Brazil Canada China Hong Kong France Germany India Italy Japan Mexico Middle East Netherlands Russia Singapore South Africa South Korea Spain Sweden Switzerland United Kingdom United States Complete list of PwC territory sites KnowledgeLine KnowledgeLines are Points of View PoV on topical issues for the Pharmaceutical Biotechnology Medical Device and Diagnostic Companies Joining the conversation Life sciences industry ventures into social media despite regulatory uncertainty June 2010 Expanding the vision of wireless health Life sciences industry can take the lead in improving patient outcomes through wireless innovation March 2010 Beyond the basics Building business value through an effective compliance program November 2009 Physician Payments Sunshine Act Healthcare reform ups the ante on transparency August 2009 Supply chain risk assessment June 2009 Achieving compliance as a competitive advantage through the updated AdvaMed Code of Ethics March 2009 Physician Sunshine Act Building value through transparency March 2009 Pharmaceuticals and life sciences Services Index of services Case studies Publications Pharma and life sciences tax news Medical Devices tax news KnowledgeLine Pharma 2020 series Video Library Press room Events Webcasts Contacts Health industries Contacts Mike Swanick Mike Swanick Global Pharmaceuticals and Life Sciences leader View complete profile Global Pharmaceuticals and Life Sciences leader Tel 1 267 330 6060 Email Douglas

    Original URL path: http://www.pwc.com/gx/en/industries/pharmaceuticals-life-sciences/publications/knowledgeline-index.html (2016-02-10)
    Open archived version from archive

  • Videos , Pharmaceuticals and life sciences: PwC
    the debate Genesis Park Diversity and inclusion Analyst relations Alumni Member firms worldwide Live events and discussions Strategy Research insights View featured Browse by issue Browse by industry Browse by service Monthly highlights Spotlight The CEO agenda CEO insights blog Careers About PwC Technology careers Employer of choice Our history PwC Professional Employability Aspire to lead PwC s series on leadership and gender equality Country job search Explore careers with Strategy Press room Facts and figures Press contacts Analyst relations Global International PwC Sites Commonly visited PwC sites Global Australia Brazil Canada China Hong Kong France Germany India Italy Japan Mexico Middle East Netherlands Russia Singapore South Africa South Korea Spain Sweden Switzerland United Kingdom United States Complete list of PwC territory sites Video library Pharmaceuticals and life sciences Services Index of services Case studies Publications Pharma and life sciences tax news Medical Devices tax news KnowledgeLine Pharma 2020 series Video Library Press room Events Webcasts Contacts Health industries Contacts Mike Swanick Mike Swanick Global Pharmaceuticals and Life Sciences leader View complete profile Global Pharmaceuticals and Life Sciences leader Tel 1 267 330 6060 Email Douglas Strang Douglas Strang Global Pharmaceuticals and Life Sciences Advisory leader View complete profile Global

    Original URL path: http://www.pwc.com/gx/en/industries/pharmaceuticals-life-sciences/videos.html (2016-02-10)
    Open archived version from archive

  • PwC pharmaceuticals: Press room
    About PwC Technology careers Employer of choice Our history PwC Professional Employability Aspire to lead PwC s series on leadership and gender equality Country job search Explore careers with Strategy Press room Facts and figures Press contacts Analyst relations Global International PwC Sites Commonly visited PwC sites Global Australia Brazil Canada China Hong Kong France Germany India Italy Japan Mexico Middle East Netherlands Russia Singapore South Africa South Korea Spain Sweden Switzerland United Kingdom United States Complete list of PwC territory sites Press room 15 November 2012 Pharma industry on cusp of golden era according to new PwC report 28 June 2012 Supreme Court Decision to Uphold Healthcare Law Means quoteGame On quote for Health Industry Crunch Time for Those Who Waited Says PwC 06 December 2011 M A surges companion diagnostics accelerates and early detection offers new prospects says PwC 21 February 2011 Patient over product Pharma needs to prepare for the future warns PwC 18 January 2011 Emerging markets are gaining ground in medical technology innovation US maintains lead finds PwC s Medical Technology Innovation Scorecard 28 April 2010 Life sciences sector captures more than one quarter of total venture capital dollars invested in q1 2010 but drops more than 20 from prior quarter according to PricewaterhouseCoopers 10 February 2010 Life sciences venture capital funding overcomes record lows outpaces other sectors according to PricewaterhouseCoopers 29 June 2009 Survey finds 90 of medical device companies adopted AdvaMed s Code of Ethics according to PricewaterhouseCoopers 29 January 2009 Biomedical industry becomes increasingly vital to state s economic stability finds California Healthcare Institute and PricewaterhouseCoopers 23 December 2008 PricewaterhouseCoopers applauds new medical device code of ethics that eliminates all gifts for doctors and lays foundation for rebuilding trust in the industry Pharmaceuticals and life sciences Services Index of services Case studies

    Original URL path: http://www.pwc.com/gx/en/industries/pharmaceuticals-life-sciences/press-releases.html (2016-02-10)
    Open archived version from archive

  • Pharmaceutical events
    Pharmaceutical Regulatory and Compliance Congress 21 23 October Washington DC PwC is a sponsor for this leading compliance event for the Pharma Industry For more information visit www pharmacongress com Phoenix Medical Device CEO Conference 21 23 October Half Moon Bay CA PwC is a co founder and sponsor www wsgr com news phoenix index htm Drug Chemical Associated Technologies Association DCAT 2015 18 March 2015 New York NY PwC will serve as both a moderator and speaker during their Cutting Edge Technologies The Future of the Pharmaceutical Value Chain program For more information visit www biopharmaconference com 2015 Latin America Compliance Conference 24 26 February 2015 Mexico City Mexico PwC is a sponsor of this AdvaMed s event bringing together compliance executives from Medtech companies with operations in Latin America For more information visit latam advamed org BioAsia 2015 2 4 January 2015 Hyderabad India BioAsia brings together global industry leaders researchers policy makers innovators and investors to discuss the future of life sciences in India For more information visit http bioasia in 11 12 December 2014 London United Kingdom A two day Congress providing an interactive and intimate discussion on practical strategies and best practices on challenges innovations technologies and concept surrounding Pharmaceutical End to End Supply Chain PwC will present on How the European Pharmaceutical Distribution Landscape Is Today and How Will It Affect Commercial Activities in Europe Johnathon Marshall Pharma Life Sciences Advisory partner PwC Steering the Future of the Healthcare Supply Chain What are the forces reshaping the environment in which the industry operates and dictating the need for a different sort of supply chain Scott A Lawson Pharma Life Sciences Advisory director PwC For more information visit http www paradigmglobalevents com events EF BF BCpharma end to end supply chain 2014 2014 Bohemian Medical Device Summit 10 12 December 2014 Prague Czech Republic PwC is a founder of this invitation only conference for CEOs medical device companies For more information visit www bohemiansummit com Pharmaceutical and Life Sciences Tax Technical Hot Topics webcast Legislative Update and Year End Accounting Update 10 December 2014 12 00pm 1 00pm US EST During the webcast PwC subject matter experts will lead discussions on the tax legislative environment and year end tax accounting considerations This session will be eligible for 1 CPE credit For more information visit http www meetpwc com rsvp invitation invitation asp id m2c53c PI2XVBUV7I6L Pharma Integrates 2014 18 19 November Riverbank Park Plaza London Under the overarching theme Strategically Transforming Pharma Relationships Pharma Integrates 2014 will attract in excess of 200 senior pharmaceutical executives representing all key stakeholder groups Participants will share their thoughts and experiences on how to encourage greater collaboration amongst key stakeholders who shape the future of the Pharma industry PwC partner Jo Pisani is sponsoring and speaking at this event For more information visit http www lifesciencesindex com CBI Tax Strategies Conference 17 18 November 2014 Philadelphia PA PwC is sponsor for this Tax Conference For more information visit www

    Original URL path: http://www.pwc.com/gx/en/industries/pharmaceuticals-life-sciences/events.html (2016-02-10)
    Open archived version from archive

  • Pharmaceutical webcasts: PwC
    PwC for a complimentary Pharmaceutical and Life Sciences Tax Technical Hot Topics webcast Successfully addressing the operational and systems requirements of the Federal Medical Device Excise Tax on Thursday 23 August 2012 from 11 00 AM 12 00 PM US EST The webcast will be hosted by Michael Swanick PwC Global Pharmaceutical and Life Sciences Tax Leader The session will be led by Advisory Services principal Carlos Moreira managing director John Moran and Tax director Fred Gordon Effective January 1 2013 manufacturers and importers of most medical devices will be subject to a 2 3 federal excise tax on sales of products made in the US By some estimates the cost of this tax will be as much as 100M 200M per year for larger organizations To comply with the requirements a fully functional automated compliance system must be designed built tested and deployed by January 2013 During the webcast PwC tax and consulting professionals will be presenting an update on the key considerations involved in developing and implementing the operational and systems requirements to meet the filing deadline The session will include case study examples to highlight how companies are meeting the data and operational challenges of building an effective system to support the tax reporting provisions Agenda Overview of PwC MDET solution approach Technology challenges and solutions Process change considerations Questions and answers session Recording details To listen to the recording of this webcast please use link http event on24 com eventRegistration prereg register jsp eventid 502226 sessionid 1 key 2BC6738F353A67716C47A61A4C0723B4 Pharma Life Sciences Tax Technical Hot Topics Webcast 22 March 2012 Impact of US Tax Reform Proposals on the Pharmaceutical and Life Sciences Industry Please join PwC for a complimentary Pharma Life Sciences Tax Technical Hot Topics webcast The Impact of US Tax Reform Proposals on the Pharmaceutical and Life Sciences Industry on Thursday March 22 2012 at 12 noon EDT The webcast will be hosted by Michael Swanick Global Pharmaceuticals and Life Sciences Tax Leader The speakers for this event will be WNTS Legislative and Regulatory Services Group Principal Don Longano and WNTS International Tax Service Principal Alan Fischl President Obama recently called on Congress to impose a minimum tax on overseas profits as part of an Administration framework for business tax reform and also has proposed that Congress enact a tax on excess returns from foreign intangible income that was included in his FY 2013 budget While President Obama outlines his tax policy goals the House and Senate tax committees are expected to focus this year primarily on laying a foundation for a future reform of U S tax laws by continuing to hold hearings on specific business and individual tax issues Interested parties also are expected to continue to offer comments on the international tax reform discussion draft issued by Ways and Means Chairman Dave Camp R MI last October as well as other territorial tax proposals being proposed in Congress During this webcast PwC tax professionals will discuss the key considerations related to the potential impact of these proposals on companies in the pharmaceutical and life sciences industry and will provide insights on the prospects for significant changes in international tax policies Who should participate Tax VPs Directors and their tax teams CFOs controllers COOs finance directors in pharmaceutical medical device and biotechnology companies Recommended CPE application of 1 CPE taxation credit is in place Webcast Registration and Login To enter the webcast please log on to the following URL 15 minutes prior to the scheduled start time http event on24 com eventRegistration prereg register jsp eventid 410892 sessionid 1 key 4ADA8701E645CC725B3DD47AC1CD87B9 Audio Only If you are unable to access the webcast audio on your PC you can access the audio via telephone Alternatively if you are connected to the webcast via your PC but are having trouble with the audio use the Non Streaming option by following the webcast link above to see the slides while you listen on the phone Note Listen only participants are NOT eligible for CPE credit Dial In Numbers listen only United States 866 219 5631 International 703 639 1122 Conference ID 1570550 NOTE Please make sure you can access the webcast in advance If for any reason you cannot open the link presentation please contact Marina Bello Valcarce at marina bello valcarce uk pwc com or Kathleen Un at kathleen un us pwc com Medical Device Tax Technical Hot Topics webcast 24 January 2012 Will you be ready Meeting the operational and systems challenges of the Federal Medical Device Excise Tax Please join PwC for a complimentary Pharmaceutical and Life Sciences Tax Technical Hot Topics webcast Will you be ready Meeting the operational and systems challenges of the Federal Medical Device Excise Tax on Tuesday 24 January 2012 from 12 00 PM 1 00 PM US EST The webcast will be hosted by Michael Swanick Global Pharmaceutical and Life Sciences Tax Leader Effective January 1 2013 manufacturers and importers of most medical devices will be subject to a 2 3 federal excise tax on sales of products made in the US By some estimates the cost of this tax will be as much as 100M 200M per year for larger organizations The tax will likely be treated similar to other federal manufacturer s excise taxes wherein companies can decide to separately state the tax on customer invoices indirect tax absorb the tax into operating margins or factor the tax into product cost To comply with the requirements a fully functional automated compliance system must be designed built tested and deployed by January 2013 During this webcast PwC tax and consulting professionals will discuss the key considerations involved in developing and implementing the operational and systems requirements i e understanding of product flow transaction terms and conditions information systems environment and other relevant information to meet the filing deadline In addition presenters will provide an overview of the medical device excise tax regulations anticipated to be released by the date of the webcast Potential issues that could

    Original URL path: http://www.pwc.com/gx/en/industries/pharmaceuticals-life-sciences/webcast.html (2016-02-10)
    Open archived version from archive

  • Global leadership contactsPharmaceutical services: PwC
    States Complete list of PwC territory sites Global leadership contacts Mike Swanick Global Pharmaceuticals and Life Sciences leader Tel 1 267 330 6060 Email Territory All Global India United Kingdom United States Douglas Strang Global Pharmaceuticals and Life Sciences Advisory leader Tel 1 267 330 3045 Email Erik Bouwman Global Pharmaceuticals and Life Sciences Tax leader Tel 31 88 792 63 22 Email Peter Kartscher Global Pharmaceuticals and Life Sciences Assurance Leader Tel 972 3 795 4410 Email Marina Bello Valcarce Global marketing and Knowledge management Tel 44 20 7212 8642 Email Brian Riewerts Principal US pharmaceuticals and life sciences 0 Tel 1 410 659 3390 Email Peter Claude Partner Tel 1 415 498 5024 Email Sujay Shetty Leader Mumbai SPO Tel 91 22 6669 1305 Email Lucy Stapleton Partner Tel 44 20 7804 2629 Email Dimitri Drone Partner Global Pharmaceutical and Life Sciences Leader PwC s Deals Practice Tel 1 617 530 4133 Email Joe Balog Tel 1 678 419 4152 Email Gregg Nahass Partner US and Global Leader M A Integration PwC s Deals Practice Los Angeles Tel 1 213 356 6245 Email Jo Pisani Email Dimitri Drone Partner Global Pharmaceutical and Life Sciences Leader PwC s Deals Practice Tel 1 617 530 4133 Email Andreas Ohl Partner Valuation Services Tel 1 646 471 2947 Email Andrew Packman UK Leader Total Tax Contribution Tel 44 0 1895 52 2104 Email Joe Braido Tel 1 973 236 4050 Email Melanie Butler Partner London Tel 44 0 20 7804 5158 Email Specialty Investigations Government Public Sector Ian Tomlinson Roe Human resources leader for Government and Public Sector Tel 44 0 20 7213 1644 Email Sandy Johnston Tel 44 0 20 7213 1952 Email Gurpreet Singh US health services advisory leader Chicago Tel 1 312 298 2160 Email Michael Mentesana Principal

    Original URL path: http://www.pwc.com/gx/en/industries/pharmaceuticals-life-sciences/pwc-team.html (2016-02-10)
    Open archived version from archive



  •